Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / Ordinary Shares, nominal value 0.05 GBP per share
-
Shares outstanding
-
84,213,667
-
Total 13F shares
-
72,226,156
-
Share change
-
+3,753,163
-
Total reported value
-
$4,575,336,285
-
Put/Call ratio
-
233%
-
Price per share
-
$63.49
-
Number of holders
-
258
-
Value change
-
+$289,861,737
-
Number of buys
-
156
-
Number of sells
-
100
Institutional Holders of Verona Pharma plc - Ordinary Shares, nominal value 0.05 GBP per share (VRNA) as of Q1 2025
As of 31 Mar 2025,
Verona Pharma plc - Ordinary Shares, nominal value 0.05 GBP per share (VRNA) was held by
258 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
72,226,156 shares.
The largest 10 holders included
PERCEPTIVE ADVISORS LLC, JANUS HENDERSON GROUP PLC, Darwin Global Management, Ltd., Frazier Life Sciences Management, L.P., EVENTIDE ASSET MANAGEMENT, LLC, RTW INVESTMENTS, LP, NEA Management Company, LLC, SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC, WELLINGTON MANAGEMENT GROUP LLP, and PRICE T ROWE ASSOCIATES INC /MD/.
This page lists
259
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.